Article Listing - US FDA modifies dosing for ESA’s Aranesp, Epogen and Procrit on cardiovascular risks

9 March 1992

British Bio-technology Group of the UK has announced the completion of Phase I testing of its injectable AIDS immunotherapeutic product,...

9 March 1992

Sandoz has launched a sustained-release formulation of the calcium channel blocker isradipine onto the French market. The product is now...

9 March 1992

Lederle Laboratories of Markham, Ontario, Canada, reports that it is now selling HibTITER in bulk form. The product represents a...

9 March 1992

Backing that Wellcome's antiretroviral product Retrovir (zidovudine) improves the survival of patients with AIDS has come from a study by...

9 March 1992

The president of the American Society of Plastic and Reconstruct-ive Surgeons, Norman Cole, has written a letter urging more than...

9 March 1992

The US Food and Drug Administra-tion has recently issued 10-15 letters on violative reminder ads for prescription drugs and is...

9 March 1992

Despite the speedy passage through Parliament of UK legislation to permit nurse prescribing, the enabling regulations are unlikely to be...

9 March 1992

Application by the US Food and Drug Administration of its fraud policy against companies suspected of wrongdoing would not slow...

9 March 1992

InterPharm Labs has receiv-ed conditional approval from Israel's Ministry of Industry and Trade to license Ares-Serono Group's worldwide rights to...

9 March 1992

Andre de Bruin is named president and chief executive officer of Boehringer Mannheim Corp, USA. He succeeds Robert Schwindt, who...

Showing 94751-94760 of 95372 articles